CORZ vs MANH: Which Stock Is the Better Buy?
Core Scientific, Inc. and Manhattan Associates, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Technology.
AI verdict — CORZ vs MANH, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Core Scientific, Inc. (CORZ) | Manhattan Associates, Inc. (MANH) | |
|---|---|---|
| Market cap | $8.4B | $8.6B |
| Revenue (latest FY) | $319.02M | $1.08B |
| Net income (latest FY) | $-288.62M | $219.95M |
| Revenue growth (5y CAGR) | 39.5% | 13.0% |
| Net margin | -90.5% | 20.3% |
| Return on equity | 30.0% | 69.9% |
| P/E ratio | — | 40.7 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 1 | 10 |
| Positive free cash flow | No | Yes |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full CORZ vs MANH breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open CORZ's full financials → Open MANH's full financials →More comparisons
Frequently asked questions
Which is bigger, CORZ or MANH?
Manhattan Associates, Inc. is larger by market capitalization — $8.6B versus $8.4B.
Which grows faster, CORZ or MANH?
Over the last five fiscal years, Core Scientific, Inc. grew revenue faster — 39.5%/yr versus 13.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.